Moderate riskFDA DrugClass II

Spectra Medical lidocaine recalled for lack of sterility assurance

Spectra Medical Devices, LLC is recalling Lidocaine HCl Injection USP in 25-count boxes of 5 mL single-dose ampules, made in South Korea, because the product lacks assurance of sterility. The FDA classified this as a Class II recall. No injuries have been reported.

From the FDA notice · Read the official notice ↗

What to do

  1. Stop using affected ampules and set aside any from the lots listed below.
  2. Affected lots: AE4013 (exp 1/31/2027); AE5032 and AE5039 (exp 3/31/2028); AE5104 (exp 8/31/2028). NDC 65282-1605-1.
  3. The notice doesn't say how to get a refund or replacement; contact Spectra Medical Devices, LLC, or where you purchased it.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Lidocaine HCl Injection USP, 25x5 mL, Single-Dose Ampules, Rx Only, Distributed by: Spectra Medical Devices, LLC, Wilmington, Made in S. Korea, NDC 65282-1605-1.
Sold in
Nationwide
Made for
All ages (0 months and older)

Details

Units affected
210625 ampules
Illnesses reported
None reported
Manufactured in
299 Ballardvale St, Ste 1, Wilmington, MA, United States
Classification
Class II
Recall number
D-0554-2026

In the FDA's words

Description
Lidocaine HCl Injection USP, 25x5 mL, Single-Dose Ampules, Rx Only, Distributed by: Spectra Medical Devices, LLC, Wilmington, Made in S. Korea, NDC 65282-1605-1. Lack of Assurance of Sterility Lot#: AE4013, Exp 1/31/2027; AE5032 & AE5039, Exp 3/31/2028; AE5104, Exp 8/31/2028. Distribution: USA Nationwide Affected quantity: 210625 ampules
Hazard
Lack of Assurance of Sterility

Related topics

SterilityDrugsSold nationwideMore from FDA Drug